Literature DB >> 9088534

Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase.

H Kolkenbrock1, A Hecker-Kia, D Orgel, N Ulbrich, H Will.   

Abstract

C-terminal truncated membrane-type 2 matrix metalloproteinase (MT2-MMP1-269), comprising prodomain and catalytic domain, was expressed as a soluble protein in Escherichia coli. Unlike the corresponding form of MT1-MMP, which can be isolated as a 31 kDa protein, MT2-MMP1-269 proved to be comparatively instable, and already the freshly isolated preparation displayed several proteins in SDS-PAGE representing MT2-MMP1-269 (33 kDa) and four N-truncated forms with N-termini methionine32 (30 kDa), isoleucine37 (30 kDa), leucine84 (24 kDa), and leucine93 (22 kDa), the catalytic domain. After thawing of frozen preparations the 33 and the 30 kDa proforms were no longer detectable in SDS-PAGE, and only the 24 and 22 kDa forms remained. The catalytic domain of MT2-MMP activated progelatinase A as well as the progelatinase A/TMP-2 complex by cleaving the 72 kDa progelatinase A to yield 67 kDa gelatinase A, which is then transformed into 62 kDa gelatinase A. The 62 kDa form is about twice as active as the 67 kDa form towards the synthetic substrate N-(2,4)-dinitrophenyl-Pro-Gln-Gly-Ile-Ala-Gly-Gln-D-Arg. No significant difference in activity was found between free and complexed gelatinase A forms. the activation of the progelatinase A/TIMP-2 complex proceeds in two steps: At first MT2-MMP is inhibited by the progelatinase A/TIMP-2/MT2-MMP, complex, whereby a ternary complex, progelatinase A/TIMP-2/ MT-2MMP is generated. This ternary complex is then activated by excess MT2-MMP. Our results suggest a mechanism for spatially regulated extracellular gelatinase A activity mediated by activation with membrane-type MMPs; Free gelatinase A is released into the extracellular space, while gelatinase A/TIMP-2 bound to MT-MMP remains anchored on the cell surface.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9088534     DOI: 10.1515/bchm.1997.378.2.71

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  12 in total

1.  Substrate recognition by gelatinase A: the C-terminal domain facilitates surface diffusion.

Authors:  I E Collier; S Saffarian; B L Marmer; E L Elson; G Goldberg
Journal:  Biophys J       Date:  2001-10       Impact factor: 4.033

2.  Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis.

Authors:  Y T Konttinen; M Ainola; H Valleala; J Ma; H Ida; J Mandelin; R W Kinne; S Santavirta; T Sorsa; C López-Otín; M Takagi
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

3.  MT2-MMP expression during early avian morphogenesis.

Authors:  Rachel A Patterson; Ann M Cavanaugh; Veronica Cantemir; Philip R Brauer; Mark V Reedy
Journal:  Anat Rec (Hoboken)       Date:  2012-11-15       Impact factor: 2.064

4.  Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers.

Authors:  N Théret; O Musso; A L'Helgoualc'h; J P Campion; B Clément
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

5.  Pathological and prognostic significance of matrix metalloproteinase-2 expression in ovarian cancer: a meta-analysis.

Authors:  Chao Liu
Journal:  Clin Exp Med       Date:  2015-06-30       Impact factor: 3.984

Review 6.  Matrix metalloproteinases in remodeling of the normal and neoplastic mammary gland.

Authors:  L A Rudolph-Owen; L M Matrisian
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

7.  Envelope gene-mediated neurovirulence in feline immunodeficiency virus infection: induction of matrix metalloproteinases and neuronal injury.

Authors:  J B Johnston; C Silva; C Power
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

8.  Expression and activation of pro-gelatinase A by human melanoma cell lines with different tumorigenic potential.

Authors:  F Capon; H Emonard; W Hornebeck; F X Maquart; P Bernard
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

9.  Differences between scirrhous and non-scirrhous human gastric carcinomas from the aspect of proMMP-2 activation regulated by TIMP-3.

Authors:  Takeyoshi Yokoyama; Hiroyuki Nakamura; Yoshihide Otani; Tetsuro Kubota; Noboru Fujimoto; Motoharu Seiki; Masaki Kitajima; Yasunori Okada
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

10.  Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.

Authors:  K Lampert; U Machein; M R Machein; W Conca; H H Peter; B Volk
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.